AbbVie Inc (NYSE:ABBV) and Allergan Plc (NYSE:AGN) have been working on the finer details of their $63 billion merger. The company has come up with an integration plan, and it is planning to keep Allergan’s aesthetic business as an independent unit. AbbVie to keep Allegan Aesthetics as an independent unit The Allergan Aesthetics unit will […]
Allergan Plc (NYSE:AGN)
The US FDA Approves Allergan Plc (NYSE:AGN)’s Ubrogepant To Cure Migraine In Adults: Allergan Expects to Launch Ubrogepant In Q1 2020
Allergan Plc (NYSE:AGN) has received the nod of the US FDA for its innovative drug – Ubrogepant to cure migraines in adults. The new drugs work by blocking the CGRP (calcitonin gene-related peptide) and offers relief for people suffering from migraine. Allergan expects to introduce Ubrogepant in Q1 2020 to treat migraines. According to the […]
Recent Posts
Colombia Oil and Gas 2023 Congress – Status and Developments Prospects of Oil and Gas industry in Latin America
Mike The Pike Productions, Inc. (OTC: MIKP) Announces Virtual Shareholder Conference July 25, 2023
Künstliche Intelligenz im Kinderherz-Zentrum
Auri Inc. – Dividend, Retirement Timelines and Expectations
Auto Parts 4Less Group, Inc. Unveils Significant Business Progress and Future Plans in Latest Investor Update
Popular Post
-
Mike The Pike Productions, Inc. (OTC: MIKP) Announces Virtual Shareholder Conference July 25, 2023
-
Sequoia Capital Raises $2.85 Billion to Fund Indian and Southeast Asian Startups
-
Futuris Company Expands With Historic Building Purchase
-
Tesla Suspends Hiring Further Set to Lay Off 10% of its Labor Force
-
Auto Parts 4Less Group, Inc. Unveils Significant Business Progress and Future Plans in Latest Investor Update
